Capstone Investments Starts Amicus Therapeutics (FOLD) at Buy
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Capstone Investments initiates coverage on Amicus Therapeutics (NASDAQ: FOLD) with a Buy. PT $7.00.
For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.
Shares of Amicus Therapeutics closed at $5.07 yesterday.
For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.
Shares of Amicus Therapeutics closed at $5.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Assumes Bravura Solutions Ltd (BVS:AU) at Neutral
- Piper Sandler Starts LightPath Technologies (LPTH) at Overweight
- JPMorgan Starts Flutter Entertainment (FLUT) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Capstone InvestmentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
